<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92452">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958554</url>
  </required_header>
  <id_info>
    <org_study_id>Mac/NMP 0917</org_study_id>
    <nct_id>NCT01958554</nct_id>
  </id_info>
  <brief_title>Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence</brief_title>
  <official_title>Randomised Controlled Trial of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Macmillan Research Group UK</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NMP Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Macmillan Research Group UK</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intimate partner violence (IPV) against women have negative mental health consequences for
      survivors; interventions designed to improve survivors' depressive symptoms and health
      status are limited.Present study evaluate the effectiveness of an integrated intervention in
      reducing intimate partner violence (IPV) improving health status.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Depression</measure>
    <time_frame>Change from Baseline in Beck Depression Inventory at 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>Change from baseline in SF-36 at 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Domestic Violence</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The integrated intervention consisted of 12 week of program and group support, based on the freedom program by pet craven. The former component was provided covering beliefs held and tactics used by the domestic violence abusers  and took about 45 minutes. It included protection and enhanced choice-making and problem-solving skills.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait list control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The group was listed in wait list and were offered the same intervention and support on completion of study period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intervention Group</intervention_name>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women over 18

          -  For those who agreed to participate

          -  Given written consent

          -  Screening for abuse was positive

        Exclusion Criteria:

          -  Screened Negative

          -  serious mental condition including suicide, hallucination, Dementia

          -  Drug or substance abuse, alcoholism

          -  Pregnant
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohini Gupta</last_name>
    <role>Principal Investigator</role>
    <affiliation>NMP Medical Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neha sharma, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Macmillan Research Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NMP medical research institute</name>
      <address>
        <city>Jaipur</city>
        <state>Rajasthan</state>
        <zip>302019</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
